Andy Trotti

139 papers receiving 16.2k citations

Andy Trotti's Hit Papers

Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522 2014 · 578 citations
5780+8+17Years since publication50010001.5k2.0k

Peers

Andy Trotti
Comparison fields: 5 of 156
  • Otorhinolaryngology 9.5k
  • Oncology 5.9k
  • Pulmonary and Respiratory Medicine 7.0k
  • Radiation 1.4k
  • Surgery 6.3k
Replace Thomas F. Pajak with:
Thomas F. Pajak United States
Jay S. Cooper United States
John A. Ridge United States
Mitchell Machtay United States
Nancy Y. Lee United States
Merrill S. Kies United States
Arlene A. Forastiere United States
Carol R. Bradford United States
Avraham Eisbruch United States
Danny Rischin Australia
Andy Trotti relative to Thomas F. Pajak United States Thomas F. Pajak's profile →
Citations per field
00.5×
Thomas F. Pajak · 1×
Citations per year

Countries citing papers authored by Andy Trotti

Since Specialization
Citations

This map shows the geographic impact of Andy Trotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andy Trotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andy Trotti more than expected).

Fields of papers citing papers by Andy Trotti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andy Trotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andy Trotti. The network helps show where Andy Trotti may publish in the future.

Co-authors

The 25 scholars most cited alongside Andy Trotti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andy Trotti Line = papers co-authored together Andy Trotti links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 143 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer
Hit paper breakdown →
20032262
2
CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment
Hit paper breakdown →
20032084
3
A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003
Hit paper breakdown →
2000983
4
Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review
Hit paper breakdown →
2003931
5
Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer
Hit paper breakdown →
2012835
6
Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy
Hit paper breakdown →
2000684
7
Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522
Hit paper breakdown →
2014578
8
Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02
Hit paper breakdown →
2010548
9
Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer
Hit paper breakdown →
2001475
10 2003407
11
Human Papillomavirus and Overall Survival After Progression of Oropharyngeal Squamous Cell Carcinoma
Hit paper breakdown →
2014394
12
American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants
Hit paper breakdown →
2008378
13
Tobacco Smoking and Increased Risk of Death and Progression for Patients With p16-Positive and p16-Negative Oropharyngeal Cancer
Hit paper breakdown →
2012359
14
p16 Protein Expression and Human Papillomavirus Status As Prognostic Biomarkers of Nonoropharyngeal Head and Neck Squamous Cell Carcinoma
Hit paper breakdown →
2014289
15 2000275
16 2010273
17 2007248
18 2001212
19 2009211
20 2002180

About Andy Trotti

Andy Trotti is a scholar working on Otorhinolaryngology, Surgery, Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 143 papers that have together received 16.6k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (92 papers), Head and Neck Surgical Oncology (25 papers), Oral health in cancer treatment (18 papers), Lung Cancer Treatments and Mutations (17 papers), Cancer Diagnosis and Treatment (14 papers), Advanced Radiotherapy Techniques (13 papers), Salivary Gland Tumors Diagnosis and Treatment (11 papers) and Ear and Head Tumors (11 papers). The work is most often cited by research in Otorhinolaryngology (9.5k citations), Oncology (5.9k citations), Pulmonary and Respiratory Medicine (7.0k citations), Radiation (1.4k citations) and Surgery (6.3k citations). Andy Trotti has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include John A. Ridge, Jay S. Cooper, Arlene A. Forastiere, Thomas F. Pajak, Randal S. Weber, Adam S. Garden, William H. Morrison, Moshe Maor, John F. Ensley and Clement K. Gwede. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology, Head & Neck, Cancer and Seminars in Radiation Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact